DTaP5-IPV-Hib-HepB, a hexavalent vaccine for infants and toddlers

DTaP5-IPV-Hib-HepB, a hexavalent vaccine for infants and toddlers

Introduction: Combination vaccines reduce the ‘shot burden’ and simplify the childhood immunization schedule. Only 5-valent DTaP-based vaccines are licensed in the U.S. Areas covered: A new combination vaccine – DTaP5-IPV-Hib-HepB – is described, which induces antibody responses in infants (given in...

Full description

Bibliographic Details
Main Authors:	Andrew W. Lee, Emilia Jordanov, Florence Boisnard, Gary S. Marshall
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2017-02-01
Series:	Expert Review of Vaccines
Subjects:	diphtheria tetanus pertussis polio hib hepatitis b hexavalent vaccine safety immunogenicity combination vaccine
Online Access:	http://dx.doi.org/10.1080/14760584.2017.1268920

Similar Items

A review of the DTaP-IPV-HB-PRP-T Hexavalent vaccine in pediatric patients
by: Andrew Dakin, et al.
Published: (2023-12-01)

Post-Marketing Safety Surveillance of a Childhood Pentavalent Diphtheria–Tetanus–Acellular Pertussis–Polio and Haemophilus influenzae Type B (DTaP-IPV//Hib) Vaccine in South Korea
by: Kuhyun Yang, et al.
Published: (2022-12-01)

Safety and Immunogenicity of Fully Liquid Hexavalent DTaP-IPV-HepB-Hib Vaccine in Healthy Infants in Russian Federation
by: L. S. Namazova-Baranova, et al.
Published: (2019-06-01)

Safety and immunogenicity of a fully-liquid DTaP-IPV-Hib-HepB vaccine (Vaxelis™) in premature infants
by: Marissa B. Wilck, et al.
Published: (2021-01-01)

DTaP-IPV-HB-Hib vaccine (Hexaxim): an update 10 years after first licensure
by: Florence Boisnard, et al.
Published: (2023-12-01)

A phase 4, open-label study to evaluate the safety and immunogenicity of DTaP5-HBV-IPV-Hib in children previously vaccinated with DTaP2-HBV-IPV-Hib or DTaP5-HBV-IPV-Hib (V419-016)
by: Andrea Guerra, et al.
Published: (2024-12-01)

Demonstration of durable hepatitis B immune memory in children vaccinated with a DTaP5-IPV-HepB-Hib infant-toddler series 7 to 8 years previously
by: Anitta Ahonen, et al.
Published: (2022-11-01)

Immunogenicity and safety of DTaP/Hib combined vaccination at different inoculation sites among infants
by: Zhen-jiang LIU, et al.
Published: (2022-02-01)

The Implementation of Pentavalent Vaccine DTaP/IPV/Hib within National Immunization Schedule
by: Irina V. Mikheeva, et al.
Published: (2019-09-01)

RESULTS OF A MULTICENTER CLINICAL STUDY OF A NEW COMBINATION VACCINE DTaP-HepB+Hib PRODUCTION OF THE CPA «MICROGEN» FOR IMMUNIZATION OF CHILDREN 6 MONTHS
by: I. V. Feldblyum, et al.
Published: (2018-04-01)

Severe immune thrombocytopenia following diphtheria, tetanus, pertussis and polio vaccination in a 36-year-old Caucasian woman: a case report
by: Onno Küster, et al.
Published: (2022-05-01)

A prospective, observational, multi-center, post-marketing safety surveillance study of the GSK combined vaccine against diphtheria, tetanus, pertussis, poliomyelitis, and Haemophilus influenzae type b invasive infections (DTaP-IPV/Hib) in South Korean infants
by: Diego Mpia Elenge, et al.
Published: (2024-12-01)

Acceptance and willingness to pay for DTaP-HBV-IPV-Hib hexavalent vaccine among parents: A cross-sectional survey in China
by: Aodi Huang, et al.
Published: (2024-12-01)

Changes in vaccination practices among infants after the introduction of DTaP-IPV/Hib combination vaccines
by: Hee-Jin Kim, et al.
Published: (2024-06-01)

Proactive surveillance on DTaP vaccination-induced adverse local reac-tions among infants in a county of Jiangsu province
by: Peng ZHANG, et al.
Published: (2024-02-01)

Guillain Barré syndrome after combined diphtheria, tetanus, and acellular pertussis (DTaP) vaccine: A rare pediatric case report and review of literature
by: Meichen Pan, et al.
Published: (2023-08-01)

Safety, immunogenicity and persistence of immune response to the combined diphtheria, tetanus, acellular pertussis, poliovirus and Haemophilus influenzae type b conjugate vaccine (DTPa-IPV/Hib) administered in Chinese infants
by: Yanping Li, et al.
Published: (2017-03-01)

A phase I, open label, clinical study to assess the safety and immunogenicity of indigenously developed liquid (DTwP-HepB-IPV-Hib) hexavalent combination vaccine in healthy toddlers aged 16–24 months
by: Hitt Sharma, et al.
Published: (2022-11-01)

Adverse events following immunization of co- and separate administration of DTaP-IPV/Hib vaccines: A real-world comparative study
by: Yiqing Zhu, et al.
Published: (2024-12-01)

A Phase I study to evaluate safety and tolerability of DTaP-IPV + Hib vaccine in healthy adult volunteers in India
by: Hitt Sharma, et al.
Published: (2023-08-01)

Comparing the pertussis antibody levels of healthy children immunized with four doses of DTap-IPV/Hib (Pentaxim) combination vaccine and DTaP vaccine in Quzhou, China
by: Zhiying Yin, et al.
Published: (2023-01-01)

Decline of serologic immunity to diphtheria, tetanus and pertussis with age suggested a full life vaccination in mainland China
by: Dandan Liu, et al.
Published: (2021-06-01)

Immunogenicity and safety of primary and booster vaccination with 2 investigational formulations of diphtheria, tetanus and Haemophilus influenzae type b antigens in a hexavalent DTPa-HBV-IPV/Hib combination vaccine in comparison with the licensed Infanrix hexa
by: Timo Vesikari, et al.
Published: (2017-07-01)

Immunization Coverage for Vaccine-Preventable Diseases in Iran from 2011 to 2021 Compared to the Level Recommended by the World Health Organization
by: Maryam Derakhshani, et al.
Published: (2022-07-01)

Impact of a dTcaP booster vaccine awareness campaign initiated by the French national health insurance for adults aged 25 years in 2021
by: Aline Hurtaud, et al.
Published: (2023-08-01)

Introduction of a hexavalent vaccine containing acellular pertussis into the national immunization program for infants in Peru: a cost-consequence analysis of vaccination coverage
by: Janice Seinfeld, et al.
Published: (2024-10-01)

Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course in healthy Korean infants: phase III, randomized study
by: Ki Hwan Kim, et al.
Published: (2019-02-01)

The Introduction of Diphtheria-Tetanus-Pertussis and Oral Polio Vaccine Among Young Infants in an Urban African Community: A Natural Experiment
by: Søren Wengel Mogensen, et al.
Published: (2017-03-01)

Post-marketing surveillance to assess the safety and tolerability of a combined diphtheria, tetanus, acellular pertussis and inactivated poliovirus vaccine (DTaP-IPV) in Korean children
by: Soon Min Lee, et al.
Published: (2019-05-01)

Surveillance on the adverse events following immunization with the pentavalent vaccine in Zhejiang, China
by: Xuejiao Pan, et al.
Published: (2022-01-01)

Immunogenicity and safety of 3-dose primary vaccination with combined DTPa-HBV-IPV/Hib in Indian infants
by: Sanjay K. Lalwani, et al.
Published: (2017-01-01)

Safety and immunogenicity of an indigenously developed tetanus toxoid, diphtheria toxoid, and acellular pertussis vaccine (Tdap) in adults, adolescents, and children in India
by: Hitt J Sharma, et al.
Published: (2023-12-01)

Immunogenicity and safety of a second booster dose of an acellular pertussis vaccine combined with reduced antigen content diphtheria-tetanus toxoids 10 years after a first booster in adolescence: An open, phase III, non-randomized, multi-center study
by: Martina Kovac, et al.
Published: (2018-08-01)

Immunogenicity test of tetanus component in adsorbed vaccines by toxin binding inhibition test
by: Denise Cristina Souza Matos, et al.
Published: (2002-09-01)

Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course and a booster dose in healthy children in Russia: a phase III, non-randomized, open-label study
by: Victor Romanenko, et al.
Published: (2020-09-01)

Adjuvant Effect of Whole-Cell Pertussis Component on Tetanus Toxoid Potency in Murine Model
by: Marta Prygiel, et al.
Published: (2023-06-01)

PROFILES OF CYTOKINES IN MICE DURING IMMUNIZATION WITH ADTP-VACCINE WITH ACELLULAR PERTUSSIS COMPONENT
by: E. M. Zaitsev, et al.
Published: (2016-12-01)

Pharmacists’ Attitudes and Practices Regarding Tetanus, Diphtheria and Pertussis (Tdap) Vaccination in Pregnancy and Surrounding Newborns
by: Christine A Echtenkamp, et al.
Published: (2018-04-01)

Access to DTP-Based Combination Vaccines in Asia–Pacific Countries between 2019 and 2022
by: Jiyan Ma, et al.
Published: (2023-12-01)

Evidence for Immunity against Tetanus, Diphtheria, and Pertussis through Natural Infection or Vaccination in Adult Solid Organ Transplant Recipients: A Systematic Review
by: Emil Lenzing, et al.
Published: (2024-04-01)